John L Lamattina - Net Worth and Insider Trading

John L Lamattina Net Worth

The estimated net worth of John L Lamattina is at least $15 Million dollars as of 2024-11-13. John L Lamattina is the Senior Vice President of Pfizer Inc and owns about 429,454 shares of Pfizer Inc (PFE) stock worth over $11 Million. John L Lamattina is the Director of Ligand Pharmaceuticals Inc and owns about 25,398 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $3 Million. John L Lamattina is also the Director of Immunome Inc and owns about 51,828 shares of Immunome Inc (IMNM) stock worth over $647,332. Details can be seen in John L Lamattina's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John L Lamattina has not made any transactions after 2021-11-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John L Lamattina

To

John L Lamattina Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John L Lamattina owns 5 companies in total, including Immunome Inc (IMNM) , Ligand Pharmaceuticals Inc (LGND) , and Larimar Therapeutics Inc (LRMR) among others .

Click here to see the complete history of John L Lamattina’s form 4 insider trades.

Insider Ownership Summary of John L Lamattina

Ticker Comapny Transaction Date Type of Owner
IMNM Immunome Inc 2021-05-24 director
LGND Ligand Pharmaceuticals Inc 2021-11-16 director
LRMR Larimar Therapeutics Inc 2015-07-13 director
LIMIT LIMIT 2007-06-15 Senior Vice President
LIMIT LIMIT 2004-03-09 director

John L Lamattina Latest Holdings Summary

John L Lamattina currently owns a total of 3 stocks. Among these stocks, John L Lamattina owns 429,454 shares of Pfizer Inc (PFE) as of June 15, 2007, with a value of $11 Million and a weighting of 75.18%. John L Lamattina owns 25,398 shares of Ligand Pharmaceuticals Inc (LGND) as of November 16, 2021, with a value of $3 Million and a weighting of 20.5%. John L Lamattina also owns 51,828 shares of Immunome Inc (IMNM) as of May 24, 2021, with a value of $647,332 and a weighting of 4.33%.

Latest Holdings of John L Lamattina

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PFE Pfizer Inc 2007-06-15 429,454 26.19 11,247,400
LGND Ligand Pharmaceuticals Inc 2021-11-16 25,398 120.74 3,066,555
IMNM Immunome Inc 2021-05-24 51,828 12.49 647,332

Holding Weightings of John L Lamattina


John L Lamattina Form 4 Trading Tracker

According to the SEC Form 4 filings, John L Lamattina has made a total of 0 transactions in Pfizer Inc (PFE) over the past 5 years. The most-recent trade in Pfizer Inc is the sale of 36,066 shares on June 15, 2007, which brought John L Lamattina around $955,028.

According to the SEC Form 4 filings, John L Lamattina has made a total of 1 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 4,835 shares on November 16, 2021, which brought John L Lamattina around $782,593.

According to the SEC Form 4 filings, John L Lamattina has made a total of 1 transactions in Immunome Inc (IMNM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Immunome Inc is the acquisition of 5,440 shares on May 24, 2021, which cost John L Lamattina around $101,021.

Insider Trading History of John L Lamattina

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John L Lamattina Trading Performance

GuruFocus tracks the stock performance after each of John L Lamattina's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John L Lamattina is -12.09%. GuruFocus also compares John L Lamattina's trading performance to market benchmark return within the same time period. The performance of stocks bought by John L Lamattina within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John L Lamattina's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John L Lamattina

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.49 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.09 LIMIT LIMIT LIMIT LIMIT LIMIT

John L Lamattina Ownership Network

Ownership Network List of John L Lamattina

No Data

Ownership Network Relation of John L Lamattina

Insider Network Chart

John L Lamattina Owned Company Details

What does Immunome Inc do?

Who are the key executives at Immunome Inc?

John L Lamattina is the director of Immunome Inc. Other key executives at Immunome Inc include SVP Operations Max Rosett , Chief Scientific Officer Jack Higgins , and director & President and CEO Clay B Siegall .

Immunome Inc (IMNM) Insider Trades Summary

Over the past 18 months, John L Lamattina made no insider transaction in Immunome Inc (IMNM). Other recent insider transactions involving Immunome Inc (IMNM) include a net purchase of 269,204 shares made by Clay B Siegall , a net purchase of 9,000 shares made by Jean Jacques Bienaime , and a net purchase of 42,300 shares made by Bruce Turner .

In summary, during the past 3 months, insiders sold 17,904 shares of Immunome Inc (IMNM) in total and bought 7,000 shares, with a net sale of 10,904 shares. During the past 18 months, 17,904 shares of Immunome Inc (IMNM) were sold and 320,504 shares were bought by its insiders, resulting in a net purchase of 302,600 shares.

Immunome Inc (IMNM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunome Inc Insider Transactions

No Available Data

John L Lamattina Mailing Address

Above is the net worth, insider trading, and ownership report for John L Lamattina. You might contact John L Lamattina via mailing address: 81 Wyman St, Post Office Box 9046, Waltham Ma 02454.